Name:
Institution:
Type:
PI
Research Objective
We expect to generate iPSC derived NK cells expressing a CAR against SARS-cov2 that could be used as an off-the-shelf therapy for COVID-19
Impact
The proposed studies will provide a novel therapeutic approach to boost the cellular immunity against SARS-cov2, especially for high risk populations.
Major Proposed Activities
The SARS-cov2 is the etiological agent of COVID-19, a global pandemic that has caused more than 4200 deaths in California. The proposed studies will provide a novel therapeutics to improve the immune response to COVID-19.